AUSTIN, Texas, Oct. 14, 2020 /PRNewswire/ — Surterra Texas, a division of the privately-held, multi-state operator cannabis company Parallel and a leading medical cannabis company in the Texas market, today announced the availability of the first cannabis-infused topical lotions for patients in the state of Texas. This introduction of lotions follows the company’s launch of medical cannabis lozenges in September, the first in the state of Texas.
Surterra Texas’ lotions are being introduced in two product lines: Tranquil™ Lotion with a 19:1 ratio of CBD:THC (342mg CBD and 18mg THC per package) and Soothe™ Lotion with a 1:1 ratio of CBD:THC (180mg CBD and 180mg THC per package). Each child-resistant jar of lotion will be available for $60.
“We are excited to be, once again, the first to bring a new cannabis product category to our patients in the state of Texas. Regardless of if a patient wants to treat a specific area with our new lotions or get full body relief from our lozenges, we’re committed to providing a variety of formats to help customers unlock the benefits of cannabis,” said Marcus Ruark, President of Surterra Texas. “Surterra Texas continues to lead the Texas Compassionate Use Program in product innovation and providing Texans with the widest variety of medical cannabis products.”
In addition to offering the first medical cannabis lotions, Surterra Texas continues to offer Texas’ only THC-dominant product, the Relief™ Lozenges with a 1:9 CBD:THC ratio, as well as a variety of medical cannabis tinctures with a range of ratios and targeted terpene profiles. Each Surterra Wellness product has been formulated with specific cannabinoid ratios to help patients with approved treatable conditions under the Texas Compassionate Use Program, including terminal cancer, spasticity, autism, multiple sclerosis, epilepsy, and a wide range of neurological diseases.
Patients interested in learning more about